Haloperidol modulates noradrenergic responses to aversive stimulation depending on treatment duration

被引:10
作者
Amato, Davide [1 ,2 ]
Natesan, Sridhar [2 ]
Kapur, Shitij [2 ]
Mueller, Christian P. [1 ,3 ]
机构
[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Sect Addict Med, D-91054 Erlangen, Germany
[2] Kings Coll London, Inst Psychiat, Dept Psychol Med & Psychiat, London WC2R 2LS, England
[3] Kings Coll London, Inst Psychiat, MRC SGDP Ctr, London WC2R 2LS, England
关键词
Haloperidol; Noradrenaline; Mini-pumps; In vivo microdialysis; PREFRONTAL CORTEX; ANTIPSYCHOTIC-DRUGS; DOPAMINE; NORADRENALINE; NOREPINEPHRINE; NEURONS; TRANSPORTERS; METABOLITES; OLANZAPINE; CLOZAPINE;
D O I
10.1016/j.bbr.2011.03.011
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Antipsychotic drugs are widely used in the treatment of schizophrenia. While their effects are considered to be due to a modulation of dopaminergic and serotonergic signaling, little is known about their effects on noradrenergic (NA) activity in the brain. In this study, rats received either a 6d or 14d treatment with haloperidol using osmotic minipumps. Noradrenaline responses to novelty, appetitive food and to an aversive tail pinch were measured in the prefrontal cortex, nucleus accumbens and caudate putamen (CPu) using in vivo microdialysis. Haloperidol significantly decreased baseline NA levels after short and long term treatment. A tail pinch significantly increased NA activity in the CPu. This effect was attenuated by haloperidol in a treatment duration-dependent way. This study suggests that haloperidol modulates NA baseline activity and reduces NA responses to mildly aversive stimuli depending on treatment duration. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:311 / 313
页数:3
相关论文
共 27 条
[1]  
AMATO D, 2011, INT J NEUROPSYCHOPH, DOI DOI 10.1017/S1461145711000010
[2]   EVIDENCE FOR A CENTRAL NORADRENALINE RECEPTOR STIMULATION BY CLONIDINE [J].
ANDEN, NE ;
CORRODI, H ;
FUXE, K ;
HOKFELT, B ;
HOKFELT, T ;
RYDIN, C ;
SVENSSON, T .
LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1970, 9 (09) :513-&
[3]   TAIL PINCH INDUCED EATING, GNAWING AND LICKING BEHAVIOR IN RATS - DEPENDENCE ON NIGROSTRIATAL DOPAMINE SYSTEM [J].
ANTELMAN, SM ;
SZECHTMAN, H ;
CHIN, P ;
FISHER, AE .
BRAIN RESEARCH, 1975, 99 (02) :319-337
[4]  
ASTONJONES G, 1991, PROG BRAIN RES, V88, P501
[5]   Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells [J].
Bryan-Lluka, LJ ;
Siebert, GA ;
Pond, SM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 360 (02) :109-115
[6]   REGIONAL DIFFERENCES IN THE REGULATION OF DOPAMINE AND NORADRENALINE RELEASE IN MEDIAL FRONTAL-CORTEX, NUCLEUS-ACCUMBENS AND CAUDATE-PUTAMEN - A MICRODIALYSIS STUDY IN THE RAT [J].
CENCI, MA ;
KALEN, P ;
MANDEL, RJ ;
BJORKLUND, A .
BRAIN RESEARCH, 1992, 581 (02) :217-228
[7]   Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex [J].
Devoto, P ;
Flore, G ;
Pani, L ;
Gessa, G .
MOLECULAR PSYCHIATRY, 2001, 6 (06) :657-664
[8]   Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens [J].
Feenstra, MGP ;
Botterblom, MHA ;
Mastenbroek, S .
NEUROSCIENCE, 2000, 100 (04) :741-748
[9]   Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy [J].
Kapur, S ;
Vanderspek, SC ;
Brownlee, BA ;
Nobrega, JN .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02) :625-631
[10]  
Kulkarni SK, 2009, INDIAN J EXP BIOL, V47, P91